JHL1101

JHL1101 · JHL Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JHL1101, covering 2020-01-09 to 2020-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare the Efficacy and Safety of JHL1101 Versus Rituximab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 3]

See pricing